Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients
Tianyu Jin,Danyu Chen,Zhicai Chen,Dujin Feng,Manqi Zheng,Peng Wang,Chao Xu
DOI: https://doi.org/10.2147/NDT.S389469
IF: 2.989
2022-11-22
Neuropsychiatric Disease and Treatment
Abstract:Tianyu Jin, 1, &ast Danyu Chen, 2, &ast Zhicai Chen, 3 Dujin Feng, 4 Manqi Zheng, 5 Peng Wang, 6 Chao Xu 6 1 Department of Neurology, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 Department of Neurology, Tongxiang First People's Hospital, Tongxiang, People's Republic of China; 3 Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, People's Republic of China; 4 Department of Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, People's Republic of China; 5 Department of Psychiatry, The Third Hospital of Quzhou, Quzhou, People's Republic of China; 6 Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chao Xu; Peng Wang, Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College. No.158 Shangtang Road, Hangzhou, People's Republic of China, 310014, Email ; Background: We aimed to investigate the association of post-thrombolytic D-dimer elevation with symptomatic intracranial hemorrhage (sICH) and functional outcome in AIS patients receiving intravenous thrombolysis. Methods: We retrospectively reviewed our database for patients with AIS who received intravenous thrombolysis between August 2018 and December 2021. ΔD-dimer was calculated as follow-up D-dimer minus baseline D-dimer. Poor functional outcome was defined as 3 months modified Rankin score (mRS) 3– 6. sICH was defined as cerebral hemorrhagic transformation in combination with clinical deterioration of National Institutes of Health Stroke Scale (NIHSS) score ≥ 4 points at 24 hours. Binary logistic regression analysis was used to investigate the association of post-thrombolytic D-dimer parameters with sICH and poor functional outcome. The receiver operating characteristic (ROC) curve derived optimal cut-off of different D-dimer parameters was determined at the maximal Youden's Index. Results: A total of 325 patients were finally included. After controlling for clinical variables, follow-up D-dimer level (OR 1.230; 95% CI 1.119 to 1.351; P < 0.001) and ΔD-dimer (OR 1.347; 95% CI 1.165 to 1.559; P < 0.001) were independently associated with poor functional outcome. Additionally, follow-up D-dimer level (OR 1.095; 95% CI 1.009 to 1.188; P = 0.030) was independently related to sICH. The optimal cut-off value of follow-up D-dimer level for predicting sICH was 4185 μg/L (area under the curve 0.760; sensitivity 76.0%; specificity 81.3%); and the optimal cut-off value of follow-up D-dimer level and ΔD-dimer as a predictor for poor functional outcome was projected to be 3838 μg/L and 2190 μg/L, which yielded a sensitivity and a specificity of 62.3%, 84.5% and 73.8%, 85.2%, respectively. Conclusion: Elevated follow-up D-dimer levels are associated with sICH and poor functional outcome in AIS patients following intravenous rt-PA. Moreover, post-thrombolytic D-dimer elevation, measured by ΔD-dimer, was a better predictive biomarker for long-term outcome at 3 months. Keywords: acute ischemic stroke, D-dimer, intravenous thrombolysis, hemorrhagic transformation, outcome Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) has been the established standard treatment in acute ischemic stroke (AIS) patients within 4.5 hours of stroke onset. 1 However, intravenous thrombolysis also increases the risk of post-thrombolytic hemorrhagic transformation (HT), particularly symptomatic intracranial hemorrhage (sICH), which is closely related to unfavorable outcome. 2–5 Therefore, it is crucial that the physician be able to assess and predict outcomes. Previous studies demonstrated that various risk factors may be attributed to poor functional outcome or the occurrence of HT after intravenous thrombolysis, including old age, severe neurological symptoms on admission, high serum glucose or diabetes mellitus history. 6 There are, however, few studies that have focused on the effect of coagulation factors on outcomes of AIS patients with intravenous thrombolysis. Since rt-PA works by activating the clot-bound plasminogen, converting plasminogen to plasmin, which in turn breaks the cross-linking strands of fibrin, and eventually dissolves the blood clot. -Abstract Truncated-
psychiatry,clinical neurology